Due to network maintenance at the University of Basel, the SWISS-MODEL website will be interrupted this weekend between 07:00 CET Saturday 17th May and 23:55 CET Sunday 18th May.

Multiple Assemblies exist for SMTL entry 8p5i
Kinase domain of mutant human ULK1 in complex with compound XMD-17-51; X-RAY DIFFRACTION 1.83 Å

SMTL ID
8p5i.1
Ligands
5,11-dimethyl-2-[(1-piperidin-4-ylpyrazol-4-yl)amino]pyrimido[4,5-b][1,4]benzodiazepin-6-one; MAGNESIUM ION; SODIUM ION
Polypeptides
Serine/threonine-protein kinase ULK1
Oligo-state
monomer
SMTL ID
8p5i.2
Ligands
5,11-dimethyl-2-[(1-piperidin-4-ylpyrazol-4-yl)amino]pyrimido[4,5-b][1,4]benzodiazepin-6-one; GLYCEROL; MAGNESIUM ION; SODIUM ION
Polypeptides
Serine/threonine-protein kinase ULK1
Oligo-state
monomer
SMTL ID
8p5i.3
Ligands
5,11-dimethyl-2-[(1-piperidin-4-ylpyrazol-4-yl)amino]pyrimido[4,5-b][1,4]benzodiazepin-6-one; GLYCEROL; MAGNESIUM ION
Polypeptides
Serine/threonine-protein kinase ULK1
Oligo-state
monomer
SMTL ID
8p5i.4
Ligands
5,11-dimethyl-2-[(1-piperidin-4-ylpyrazol-4-yl)amino]pyrimido[4,5-b][1,4]benzodiazepin-6-one; MAGNESIUM ION; SODIUM ION
Polypeptides
Serine/threonine-protein kinase ULK1
Oligo-state
monomer